Nishimura R, Fujiki Y, Taira T, Miyaki T, et al. The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes. Clin Breast Cancer 2024 Feb 22:S1526-8209(24)00051.
PMID: 38472058